Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Abstract
Inflammation is a fundamental innate immune response to perturbed tissue homeostasis. Chronic inflammatory processes affect all stages of tumour development as well as therapy. In this Review, we outline the principal cellular and molecular pathways that coordinate the tumour-promoting and tumour-antagonizing effects of inflammation and we discuss the crosstalk between cancer development and inflammatory processes. In addition, we discuss the recently suggested role of commensal microorganisms in inflammation-induced cancer and we propose that understanding this microbial influence will be crucial for targeted therapy in modern cancer treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while the intestinal microbiota can promote local inflammation and development of gastrointestinal cancers (Elinav et al., 2013; Garrett, 2015), it can exert an opposing effect on transplanted tumors at distal sites by priming the host immune system and enhancing the systemic anti-tumor immune response (Dzutsev et al., 2017).”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Elinav et al., 2013
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Cited by
Items 101–200 of 1,001
Metastatic Tumors to the Jaws and Mouth
Hirshberg, A., Berger, R., Allon, I., & Kaplan, I. (2014) · Head and Neck Pathology · doi:10.1007/s12105-014-0591-z · Cited by 208
Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment
Hanna, A., & Shevde, L. A. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0509-3 · Cited by 205
He, Z., & Zhang, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741305 · Cited by 203
The microbiota programs DNA methylation to control intestinal homeostasis and inflammation
Ansari, I., Raddatz, G., Gutekunst, J., Ridnik, M., Cohen, D., Abu-Remaileh, M., Tuganbaev, T., Shapiro, H., Pikarsky, E., Elinav, E., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0659-3 · Cited by 202
Self-citationFusobacterium nucleatum and oral cancer: a critical review
McIlvanna, E., Linden, G. J., Craig, S. G., Lundy, F. T., & James, J. A. (2021) · BMC Cancer · doi:10.1186/s12885-021-08903-4 · Cited by 198
Miao, Z., Jiang, S., Ding, M., Sun, S., Ma, Y., Younis, M. R., He, G., Wang, J., Lin, J., Cao, Z., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b05035 · Cited by 197
Translating p53-based therapies for cancer into the clinic
Peuget, S., Zhou, X., & Selivanova, G. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-023-00658-3 · Cited by 190
Lu, H., Xu, X., Fu, D., Gu, Y., Fan, R., Yi, H., He, X., Wang, C., Ouyang, B., Zhao, P., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.07.003 · Cited by 190
Alvarado, A. G., Thiagarajan, P. S., Mulkearns-Hubert, E. E., Silver, D. J., Hale, J. S., Alban, T. J., Turaga, S. M., Jarrar, A., Reizes, O., Longworth, M. S., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.12.001 · Cited by 187
Integration of Innate Immune Signaling
Thaiss, C. A., Levy, M., Itav, S., & Elinav, E. (2016) · Trends in Immunology · doi:10.1016/j.it.2015.12.003 · Cited by 185
Self-citationInflammation and cancer: What a surgical oncologist should know
Dupré, A., & Malik, H. Z. (2018) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2018.02.209 · Cited by 182
Genetic determinants of co-accessible chromatin regions in activated T cells across humans
Gate, R. E., Cheng, C. S., Aiden, A. P., Siba, A., Tabaka, M., Lituiev, D., Machol, I., Gordon, M. G., Subramaniam, M., Shamim, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0156-2 · Cited by 181
“These studies have provided foundational resources for understanding the genetic basis of gene regulation in resting cells, but many disease states are associated with immune cell activation 24,25 .”
Stojkovic Lalosevic, M., Pavlovic Markovic, A., Stankovic, S., Stojkovic, M., Dimitrijevic, I., Radoman Vujacic, I., Lalic, D., Milovanovic, T., Dumic, I., & Krivokapic, Z. (2019) · Disease Markers · doi:10.1155/2019/6036979 · Cited by 181
Heparanase and the hallmarks of cancer
Jayatilleke, K. M., & Hulett, M. D. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02624-1 · Cited by 184
Phytochemicals targeting NF-κB signaling: Potential anti-cancer interventions
Chauhan, A., Islam, A., Prakash, H., & Singh, S. K. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.07.002 · Cited by 180
Zhao, Y., & Jiang, Q. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa104 · Cited by 180
Microbiota regulate innate immune signaling and protective immunity against cancer
Xing, C., Wang, M., Ajibade, A. A., Tan, P., Fu, C., Chen, L., Zhu, M., Hao, Z.-Z., Chu, J., Yu, X., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.03.016 · Cited by 157
Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer
Fang, T., Wang, Y., Yin, X., Zhai, Z., Zhang, Y., Yang, Y., You, Q., Li, Z., Ma, Y., Li, C., et al. (2020) · Journal of Immunology Research · doi:10.1155/2020/9146042 · Cited by 178
Ma, S., Song, W., Xu, Y., Si, X., Lv, S., Zhang, Y., Tang, Z., & Chen, X. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b05265 · Cited by 178
Lu, C., Talukder, A., Savage, N. M., Singh, N., & Liu, K. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1291106 · Cited by 176
Association of oral dysbiosis with oral cancer development (Review)
Rosa, G. R. M. L., Gattuso, G., Pedull�, E., Rapisarda, E., Nicolosi, D., & Salmeri, M. (2020) · Oncology Letters · doi:10.3892/ol.2020.11441 · Cited by 175
An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease
Choy, M. C., Visvanathan, K., & Cruz, P. P. D. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000955 · Cited by 176
Nazir, Y., Hussain, S. A., Abdul Hamid, A., & Song, Y. (2018) · BioMed Research International · doi:10.1155/2018/3428437 · Cited by 156
Bioactive Egg Components and Inflammation
Andersen, C. J. (2015) · Nutrients · doi:10.3390/nu7095372 · Cited by 175
Candida albicans and cancer: Can this yeast induce cancer development or progression?
Ramirez-Garcia, A., Rementeria, A., Aguirre-Urizar, J. M., Moragues, M. D., Antoran, A., Pellon, A., Abad-Diaz-de-Cerio, A., & Hernando, F. L. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.913004 · Cited by 119
Role of Reactive Oxygen Species in Aging and Age-Related Diseases: A Review
Anik, M. I., Mahmud, N., Masud, A. A., Khan, M. I., Islam, M. N., Uddin, S., & Hossain, M. K. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00411 · Cited by 173
Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer
Liu, Z., Jin, K., Guo, M., Long, J., Liu, L., Liu, C., Xu, J., Ni, Q., Luo, G., & Yu, X. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5579-3 · Cited by 169
Zuo, H., Ueland, P. M., Ulvik, A., Eussen, S. J. P. M., Vollset, S. E., Nygård, O., Midttun, Ø., Theofylaktopoulou, D., Meyer, K., & Tell, G. S. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv242 · Cited by 167
Inflammation in cancer: therapeutic opportunities from new insights
Xie, Y., Liu, F., Wu, Y., Zhu, Y., Jiang, Y., Wu, Q., Dong, Z., & Liu, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02243-8 · Cited by 167
Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location
Zhang, L., Zhao, Y., Dai, Y., Cheng, J.-N., Gong, Z., Feng, Y., Sun, C., Jia, Q., & Zhu, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01578 · Cited by 166
Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer
Fan, X., Jin, Y., Chen, G., Ma, X., & Zhang, L. (2021) · Digestion · doi:10.1159/000508328 · Cited by 166
Host Immune Response to Infection and Cancer: Unexpected Commonalities
Goldszmid, R. S., Dzutsev, A., & Trinchieri, G. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.003 · Cited by 165
Cold‐inducible RNA binding protein in cancer and inflammation
Lujan, D. A., Ochoa, J. L., & Hartley, R. S. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1462 · Cited by 165
Kowalik, A., Kowalewska, M., & Góźdź, S. S. (2017) · Translational research · doi:10.1016/j.trsl.2017.04.002 · Cited by 165
Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1
Najjar, M., Suebsuwong, C., Ray, S. S., Thapa, R. J., Maki, J. L., Nogusa, S., Shah, S., Saleh, D., Gough, P. J., Bertin, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.052 · Cited by 147
Zhu, Q., Man, S. M., Gurung, P., Liu, Z., Vogel, P., Lamkanfi, M., & Kanneganti, T.-D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402051 · Cited by 153
Helicobacter pylori Vacuolating Toxin and Gastric Cancer
McClain, M. S., Beckett, A. C., & Cover, T. L. (2017) · Toxins · doi:10.3390/toxins9100316 · Cited by 163
Pickering, C. R., Zhang, J., Neskey, D. M., Zhao, M., Jasser, S. A., Wang, J., Ward, A. M., Tsai, C. J., Alves, M. V. O., Zhou, J. H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0565 · Cited by 162
Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities
Efferth, T., & Oesch, F. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.015 · Cited by 161
Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer
Yan, J., Smyth, M. J., & Teng, M. W. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028530 · Cited by 149
Louwen, F., Ritter, A., Kreis, N. N., & Yuan, J. (2018) · Obesity Reviews · doi:10.1111/obr.12679 · Cited by 160
Epigenome-based cancer risk prediction: rationale, opportunities and challenges
on behalf of the FORECEE (4C) Consortium, Widschwendter, M., Jones, A., Evans, I., Reisel, D., Dillner, J., Sundström, K., Steyerberg, E. W., Vergouwe, Y., Wegwarth, O., et al. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.30 · Cited by 160
The gasdermin family: emerging therapeutic targets in diseases
Zhu, C., Xu, S., Jiang, R., Yu, Y., Bian, J., & Zou, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01801-8 · Cited by 162
Wei, X.-L., Wang, F.-H., Zhang, D.-S., Qiu, M.-Z., Ren, C., Jin, Y., Zhou, Y.-X., Wang, D.-S., He, M.-M., Bai, L., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1379-6 · Cited by 159
Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study
Fu, L., Tian, T., Yao, K., Chen, X.-F., Luo, G., Gao, Y., Lin, Y.-F., Wang, B., Sun, Y., Zheng, W., et al. (2022) · JMIR Public Health and Surveillance · doi:10.2196/34874 · Cited by 159
Macrophage Migration Inhibitory Factor (MIF): Biological Activities and Relation with Cancer
Nobre, C. C. G., de Araújo, J. M. G., Fernandes, T. A. A. D. M., Cobucci, R. N. O., Lanza, D. C. F., Andrade, V. S., & Fernandes, J. V. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-016-0138-6 · Cited by 159
Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy
Singer, J. W., Fleischman, A. G., Al‐Fayoumi, S., Mascarenhas, J. O., Yu, Q., & Agarwal, A. (2018) · Oncotarget · doi:10.18632/oncotarget.26058 · Cited by 160
The inflammatory inception of gallbladder cancer
Espinoza, J. A., Bizama, C., García, P., Ferreccio, C., Javle, M. M., Miquel, J. F., Koshiol, J. E., & Roa, J. C. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.03.004 · Cited by 158
Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma
Kitano, Y., Okabe, H., Yamashita, Y.-I., Nakagawa, S., Saito, Y., Umezaki, N., Tsukamoto, M., Yamao, T., Yamamura, K., Arima, K., et al. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.401 · Cited by 144
Pateras, I. S., Havaki, S., Nikitopoulou, X., Vougas, K. N., Townsend, P. A., Panayiotidis, M. I., Georgakilas, A. G., & Gorgoulis, V. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.011 · Cited by 158
Michels, N., van Aart, C., Morisse, J., Mullee, A., & Huybrechts, I. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103177 · Cited by 154
Immune Landscape of Breast Cancers
Nagarajan, D., & McArdle, S. (2018) · Biomedicines · doi:10.3390/biomedicines6010020 · Cited by 152
Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment
Ajona, D., Ortiz‐Espinosa, S., & Pío, R. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.11.023 · Cited by 153
Tumor-induced generation of splenic erythroblast-like Ter-cells promotes tumor progression.
Han, Y., Liu, Q., Hou, J., Gu, Y., Zhang, Y., Chen, Z., Fan, J., Zhou, W., Qiu, S., Zhang, Y., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.061 · Cited by 150
Systemic Inflammation in Midlife: Race, Socioeconomic Status, and Perceived Discrimination
Stepanikova, I., Bateman, L. B., & Oates, G. R. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.09.026 · Cited by 141
ROS: A “booster” for chronic inflammation and tumor metastasis
Chen, A., Huang, H., Fang, S., & Hang, Q. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189175 · Cited by 151
Tumour cell invasion: an emerging role for basal epithelial cell extrusion
Slattum, G. M., & Rosenblatt, J. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3767 · Cited by 148
Vizcaino, M. I., Engel, P., Trautman, E., & Crawford, J. M. (2014) · Journal of the American Chemical Society · doi:10.1021/ja503450q · Cited by 135
Tokunaga, R., Sakamoto, Y., Nakagawa, S., Ohuchi, M., Izumi, D., Kosumi, K., Taki, K., Higashi, T., Miyamoto, Y., Yoshida, N., et al. (2016) · International Journal of Colorectal Disease · doi:10.1007/s00384-016-2668-5 · Cited by 148
Balancing the innate immune system in tumor development
Hagerling, C., Casbon, A.-J., & Werb, Z. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.001 · Cited by 133
Fusobacterium and Enterobacteriaceae: Important players for CRC?
Allen-Vercoe, E., & Jobin, C. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.05.014 · Cited by 133
Hanna, B. S., McClanahan, F., Yazdanparast, H., Zaborsky, N., Kalter, V., Rößner, P. M., Benner, A., Dürr, C., Egle, A., Gribben, J. G., et al. (2015) · Leukemia · doi:10.1038/leu.2015.305 · Cited by 144
Mechanistic Effects of Calcitriol in Cancer Biology
Díaz, L., Díaz‐Muñoz, M., García-Gaytán, A. C., & Méndez, I. G. (2015) · Nutrients · doi:10.3390/nu7065020 · Cited by 143
Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients
Hu, H. W., Yao, X., Xie, X., Wu, X., Zheng, C., Xia, W., & Ma, S. (2016) · World Journal of Urology · doi:10.1007/s00345-016-1864-9 · Cited by 142
Yu, Y., Qian, L., & Cui, J. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1342 · Cited by 133
Targeting myeloid cells in the tumor sustaining microenvironment
Schupp, J., Krebs, F. K., Zimmer, N., Trzeciak, E., Schuppan, D., & Tuettenberg, A. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.013 · Cited by 126
Dietary polyphenols: A novel strategy to modulate microbiota-gut-brain axis
Serra, D., Almeida, L. M., & Dinis, T. C. P. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.06.007 · Cited by 130
Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies
Rahman, M. M., Islam, M. R., Shohag, S., Ahasan, M. T., Sarkar, N., Khan, H., Hasan, A. M., Cavalu, S. D., & Rauf, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112898 · Cited by 142
Sadrekarimi, H., Gardanova, Z. R., Bakhshesh, M., Ebrahimzadeh, F., Yaseri, A. F., Thangavelu, L. P., Hasanpoor, Z., Zadeh, F. A., & Kahrizi, M. S. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03492-7 · Cited by 143
Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
Shaked, Y. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.57 · Cited by 140
Regulation of inflammation by members of the formyl-peptide receptor family
Chen, K., Bao, Z., Gong, W., Tang, P., Yoshimura, T., & Wang, J. M. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.06.012 · Cited by 135
Inhibiting cancer cell hallmark features through nuclear export inhibition
Sun, Q., Chen, X., Zhou, Q., Burstein, E., Yang, S., & Jia, D. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2016.10 · Cited by 140
Cellular Interactions in the Tumor Microenvironment: The Role of Secretome
da Cunha, B. R., Domingos, C., Stefanini, A. C. B., Henrique, T., Polachini, G. M., Castelo‐Branco, P., & Tajara, E. H. (2019) · Journal of Cancer · doi:10.7150/jca.21780 · Cited by 141
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors
Canning, P., Ruan, Q., Schwerd, T., Hrdinka, M., Maki, J. L., Saleh, D., Suebsuwong, C., Ray, S. S., Brennan, P. E., Cuny, G. D., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.07.017 · Cited by 139
Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells
Poggi, A. D., Musso, A., Dapino, I., & Zocchi, M. R. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.03.001 · Cited by 138
Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination
Kathania, M., Khare, P. S., Zeng, M., Cantarel, B. L., Zhang, H., Ueno, H., & Venuprasad, K. (2016) · Nature Immunology · doi:10.1038/ni.3488 · Cited by 137
Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications
Baba, Y., Iwatsuki, M., Yoshida, N., Watanabe, M., & Baba, H. (2017) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12014 · Cited by 123
The biological implications of Yin Yang 1 in the hallmarks of cancer
Meliala, I. T. S., Hosea, R., Kasim, V., & Wu, S. (2020) · Theranostics · doi:10.7150/thno.43481 · Cited by 135
Piccinno (2025) · doi:10.1038/s41591-025-03693-9 · Cited by 133
Microbial imbalance and intestinal pathologies: connections and contributions
Yang, Y., & Jobin, C. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016428 · Cited by 113
MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential
Penticuff, J. C., Woolbright, B. L., Sielecki, T. M., Weir, S. J., & Taylor, J. A. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0171-9 · Cited by 132
Emerging Concepts Linking Obesity with the Hallmarks of Cancer
Donohoe, C. L., Lysaght, J., O'Sullivan, J. N., & Reynolds, J. V. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.08.004 · Cited by 132
Cancer-inducing niche: the force of chronic inflammation
Afify, S. M., Hassan, G., Seno, A., & Seno, M. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01775-w · Cited by 130
Zhou, J., Zhao, W., Miao, Z., Wang, J., Ma, Y., Wu, H., Sun, T., Qian, H., & Zha, Z. (2020) · ACS Nano · doi:10.1021/acsnano.9b08894 · Cited by 128
Combinatorial therapy in tumor microenvironment: Where do we stand?
Kumari, S., Advani, D., Sharma, S., Ambasta, R. K., & Kumar, P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188585 · Cited by 130
Jia, B., Zhang, B., Li, J., Qin, J., Huang, Y., Huang, M., Ming, Y., Jiang, J., Chen, R., Xiao, Y., et al. (2024) · Chemical Society Reviews · doi:10.1039/d3cs01039b · Cited by 128
Mechanisms of Immune Signaling in Colitis-Associated Cancer
Waldner, M. J., & Neurath, M. F. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.006 · Cited by 118
Murine Model for Colitis-Associated Cancer of the Colon
Snider, A. J., Bialkowska, A. B., Ghaleb, A. M., Yang, V. W., Obeid, L. M., & Hannun, Y. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3661-8_14 · Cited by 130
Sánchez‐Alcoholado, L., Ordóñez, R., Otero, A. P., Plaza-Andrades, I. J., Laborda-Illanes, A., Medina, J. A., Ramos‐Molina, B., Gómez‐Millán, J., & Queipo‐Ortuño, M. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186782 · Cited by 127
Zeligs, K. P., Neuman, M. K., & Annunziata, C. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1374 · Cited by 116
Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer
Zhang, K., Hua, Y., Wang, D., Chen, L., Wu, C., Chen, Z., Liu, L., & Chen, H. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1782-x · Cited by 126
CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer
Wang, B., Wang, M., Ao, D., & Wei, X. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188799 · Cited by 127
Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle
García-Castillo, V., Sanhueza, E., McNerney, E. M., Oñate, S. A., & García, A. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000371 · Cited by 125
Guo, Y., Nie, Q. H., MacLean, A. L., Li, Y., Lei, J., & Li, S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1662 · Cited by 125
Xu, L., Lin, W., Wen, L., & Li, G. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1288-8 · Cited by 125
Jia, D., Yang, W., Li, L., Liu, H., Tan, Y., Ooi, S., Chi, L., Filion, L. G., Figeys, D., & Wang, L. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.145 · Cited by 113
The micro(nano)plastics perspective: exploring cancer development and therapy
Deng, X., Gui, Y., & Zhao, L. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02230-z · Cited by 124
Chen, Z., Shao, Y., Fan, M., Zhuang, Q., Wang, K., Cao, W., Xu, X., & He, X. (2015) · PubMed · Cited by 123
Li, J., Cao, D., Huang, Y. C., Xiong, Q., Tan, D., Liu, L., Lin, T., & Wei, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865643 · Cited by 123
Multiple Roles of Toll-Like Receptor 4 in Colorectal Cancer
Yesudhas, D., Gosu, V., Anwar, M. A., & Choi, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00334 · Cited by 124
Metadata
- Authors
- Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A.
- Affiliations
- Weizmann Institute of Science (IL)
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Elinav, Eran
- Flavell, Richard A.
- Venue
- Nature reviews. Cancer
- Published
- 2013-10-24
- Volume
- 13
- Issue
- 11
- Pages
- 759-771
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2143841612
- Cited by
- 2,000
- References
- 154
- Citations by year
- 2026: 83 · 2025: 150 · 2024: 223 · 2023: 167 · 2022: 204 · 2021: 187 · 2020: 202 · 2019: 132 · 2018: 144 · 2017: 149 · 2016: 142 · 2015: 124 · 2014: 90 · 2013: 2
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- inflammation-associated tumorigenesis, chronic inflammation, tumor progression, tumor microenvironment, gut microbiota, commensal microorganisms, innate immunity, cancer therapy
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Homeostasis, Humans, Immunity, Innate, Inflammation, Neoplasm Metastasis, Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Genome, Cell Proliferation, Mice, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.